Brian Halak Insider Profile
4 Followers
Brian Halak, Ten Percent Owner at Veracyte, holds 327.00 shares in Alimera (Ticker: ALIM), holds 2.61M shares in Dicerna Pharma (Ticker: DRNA), holds 0.00 shares in Cadence Pharma (Ticker: CADX).
Brian Halak's Trading History
| ALIMAlimera | Sep 17, 2021 | ― | Uninformative Buy | ― | $1.81K | |
| DRNADicerna Pharma | Nov 06, 2018 | ― | Informative Sell | 4.46M | $99.59M | |
| CADXCadence Pharma | Mar 21, 2014 | ― | Uninformative Sell | 42.71M | ― | |
| AKAOQAchaogen | Mar 17, 2014 | ― | Uninformative Buy | ― | $847.25 | |
| VCYTVeracyte | Nov 04, 2013 | Ten Percent Owner | Uninformative Buy | ― | $553.02K | |
| EVOKEvoke Pharma | Sep 30, 2013 | ― | Uninformative Buy | ― | $266.82K | |
| TBRATobira Therapeutics | Aug 21, 2013 | ― | Informative Buy | ― | $722.73K | |
| OCRXOcera Therapeutics | Jul 15, 2013 | ― | Informative Buy | 7.99M | $6.31M | |
| ESPREsperion | Jul 02, 2013 | ― | Uninformative Buy | ― | $112.10K | |
| ~ACHNAchillion Pharmaceuticals | Jan 18, 2013 | ― | Uninformative Sell | ― | $1.65M | |
| CLPMCelator Pharmaceuticals | Jan 14, 2013 | ― | Informative Buy | ― | $177.45K | |
| DRTXDurata | Jul 24, 2012 | ― | Uninformative Buy | ― | ― | |
| OREXQOrexigen | Dec 22, 2011 | ― | Informative Buy | 680.26K | $253.22 | |
| CLVSQClovis Oncology | Nov 21, 2011 | ― | Uninformative Buy | ― | $765.20 | |
| ZGNXZogenix | Sep 20, 2011 | ― | Informative Buy | 7.00M | $4.52M | |
| VNDAVanda | Mar 29, 2010 | Director | Uninformative Buy | ― | $29.03K | |
| VOLCVolcano Corp | ― | ― | ― | ― | ||
| PRTKParatek Pharmaceuticals | ― | ― | ― | $223.79K |
You May Also Like
Brian Halak insider profile FAQ
What is the percentage of profitable transactions made by Brian Halak?
The percentage of profitable transactions made by Brian Halak is 0%.
What is the average return per transaction made by Brian Halak?
The average return per transaction made by Brian Halak is -24.50%.
What stocks does Brian Halak hold?
Brian Halak holds: VCYT, DRNA, ALIM, OCRX, CLVSQ, ZGNX, ~ACHN, ESPR, AKAOQ, TBRA, OREXQ, VNDA, EVOK, CLPM, CADX, PRTK, VOLC, DRTX stocks.
What was Brian Halak's most profitable transaction?
Brian Halak’s most profitable transaction was an Informative Sell of DRNA stock on November 6, 2018. The return on the trade was -20.50%.
What is Brian Halak's role in Veracyte?
Brian Halak's role in Veracyte is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
